Home › Funds › D. E. Shaw & Co › BVS
D. E. Shaw & Co position in BVS
BIOVENTUS INC · Health Care
Latest position (Q2 2026)47.30K sh
Reported value held$446.55K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 15.02K | $213.00K | New |
| Q4 2022 | 12.60K | $32.89K | New |
| Q1 2023 | 18.30K | $19.58K | Add |
| Q4 2023 | 35.91K | $189.25K | New |
| Q2 2024 | 197.18K | $1.13M | New |
| Q3 2024 | 321.63K | $3.84M | Add |
| Q4 2024 | 160.66K | $1.69M | Reduce |
| Q1 2025 | 167.75K | $1.53M | Add |
| Q2 2025 | 70.44K | $466.33K | Reduce |
| Q3 2025 | 188.89K | $1.26M | Add |
| Q4 2025 | 358.26K | $2.67M | Add |
| Q1 2026 | 310.61K | $2.84M | Reduce |
| Q2 2026 | 47.30K | $446.55K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BVS
- BlackRock Inc 3.44M sh · $32.44M · Q2 2026
- Vanguard Group 2.98M sh · $22.21M · Q4 2025
- Royce & Associates 1.83M sh · $17.31M · Q2 2026
- Geode Capital Management 1.37M sh · $12.89M · Q2 2026
- Wellington Management Group 748.36K sh · $7.06M · Q2 2026
- Renaissance Technologies 736.00K sh · $6.95M · Q2 2026
- Goldman Sachs Group 652.37K sh · $6.16M · Q2 2026
- Fidelity Management & Research (FMR) 452.85K sh · $4.27M · Q2 2026
- Northern Trust Corp 443.82K sh · $4.19M · Q2 2026
- Prudential Financial 394.52K sh · $3.72M · Q2 2026
- Charles Schwab Investment Management 391.86K sh · $3.70M · Q2 2026
- AQR Capital Management 326.12K sh · $3.08M · Q2 2026